Abstract
We compared risk of recurrent fever in patients with acute myeloid leukemia undergoing induction chemotherapy with febrile neutropenia without an infectious source in which antibacterials were de-escalated before neutrophil recovery versus continued. There was less recurrent fever when antibacterials were de-escalated early with no increased adverse events.
Original language | English |
---|---|
Article number | ofaa138 |
Journal | Open Forum Infectious Diseases |
Volume | 7 |
Issue number | 5 |
DOIs | |
State | Published - 2020 |
Keywords
- Acute myeloid leukemia
- Antimicrobial stewardship
- Neutropenic fever